ResearcherEast Carolina UniversityNo recent work listed

Rachel L. Roper

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6971-7745; OpenAlex author ID A5053962751. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper

Papers 2

Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer. Last author DOI 10.1371/journal.pone.0193131 ↗
Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer. Last author DOI 10.1186/s13046-016-0314-2 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Emmanuel E. Zervos · 2 shared papers, 2016–2018 · strength 0.18
- Paper Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer. DOI 10.1371/journal.pone.0193131 ↗
- Paper Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer. DOI 10.1186/s13046-016-0314-2 ↗
Michael A. White · 1 shared paper, 2018 · strength 0.11
- Paper Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer. DOI 10.1371/journal.pone.0193131 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.